Summit Therapeutics
SMMT
#1319
Rank
NZ$23.83 B
Marketcap
$32.32
Share price
-5.55%
Change (1 day)
643.56%
Change (1 year)

Summit Therapeutics (SMMT) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.86 Billion

According to Summit Therapeutics 's latest financial reports the company has NZ$0.86 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Summit Therapeutics - Cash on Hand chart (from 2020 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.29 B-46.36%
2022-12-31NZ$0.54 B422.41%
2021-12-31NZ$0.10 B14.18%
2020-12-31NZ$92.04 M
2019-01-31NZ$66.96 M22.03%
2018-01-31NZ$54.87 M-8.69%
2017-01-31NZ$60.1 M17.82%
2016-01-31NZ$51.01 M44.98%
2015-01-31NZ$35.18 M420.72%
2014-01-31NZ$6.75 M-32.99%
2013-01-31NZ$10.08 M61.36%
2012-01-31NZ$6.24 M-40.93%
2011-01-31NZ$10.58 M-52.1%
2010-01-31NZ$22.08 M103.03%
2009-01-31NZ$10.87 M-78.54%
2008-01-31NZ$50.7 M-50.36%
2007-01-31NZ$0.10 B74.75%
2006-01-31NZ$58.44 M-17.09%
2005-01-31NZ$70.49 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$2.12 B 146.13%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.43 B-49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.17 B-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA